anti-HIV
Dendrimers as a Novel Carrier in Anti-HIV Therapy
... laboratory-isolated HIV-1 as efficiently as dextran ...The anti-HIV activity of dendrimers and glycodendrimers is being extensively ...some anti-HIV ...of anti-HIV ...
6
Glycosyl-Phosphatidylinositol-Anchored Anti-HIV Env Single-Chain Variable Fragments Interfere with HIV-1 Env Processing and Viral Infectivity
... from HIV-1 ...for HIV-1 CCR5 (50) and CXCR4 (51, 52) via a number of RNA-based approaches such as ribozymes, short hairpin RNA (shRNA), and RNA inter- ference (RNAi) (53–55), or by introducing mutations ...
15
Dual anti HIV mechanism of clofarabine
... for HIV-1 runs into the specter of hydroxyurea, an RNRI which failed clinically as an anti-HIV drug due primarily to its accentuation of NRTI toxicity ...an HIV drug would require further drug ...
12
IN VITRO ANTI HIV ACTIVITY STUDIES ON ENICOSTEMA LITTORALE (LAM), RAYNAL WHOLE PLANTS
... with HIV-1 virus stock (20 TCID) and incubated overnight at 37 ° ...drug. Anti-HIV activity was analyzed by measuring supernatant p24 antigen according to the Manufacturer’s protocol (Vironostika, ...
10
Maternal but Not Infant Anti HIV 1 Neutralizing Antibody Response Associates with Enhanced Transmission and Infant Morbidity
... although HIV-1-specific nAbs were efficiently transferred from mother to infant; they were not a correlate of protection from HIV-1 breast milk ...Surprisingly, HIV-1-infected TMs compared to NTMs ...
19
Viral Diversity by Deep Sequencing: Approaches to Analyzing Effects of Anti-HIV Treatments
... targeting HIV genomic RNA provide a mechanism to control the ...inhibited HIV in tissue culture studies and mice offering an attractive choice for anti-‐HIV gene therapy ...against HIV ...
142
Anti HIV triterpenoid components
... In the series of C-3 acid group of triterpene derivative, such as malonate mono-ester, reveal obvious anti-protease activity. The polar-fuction group of C-3 side chain of triterpene derivative play an important ...
6
Effects of Cellular Activation on Anti-HIV-1 Restriction Factor Expression Profile in Primary Cells
... of HIV-1 variants lacking a functional vif ...into HIV-1 virions and deaminates cytosines to uracils in replication intermediates, providing tem- plates for lethal guanine-to-adenine mutations ...other ...
6
APPROCHES TO ANTI-HIV CHEMOTHERAPY
... 4. Louis N Jungheim, Timoting A., Angela J Baxter, “Potent human Immunodeficiency Virus Type-I Protease Inhibitors that utilize Non-coded D- amino acids as P2/P3 Ligands” Journal of Medicinal chemistry, 1996, 39(1), 96. ...
13
Anti-HIV/AIDS Drugs: An Overview
... genes in the blood is helpful in assessing the efficacy of treatments. There is no cure for AIDS, but it may be treated with a number of different antiretroviral drugs, often in combination. Early treatment with ...
10
SYNTHESIS, GREEN METRICS EVALUATION AND ANTIBACTERIAL ACTIVITY OF 3,4,5 TRIMETHOXY–N [SUBSTITUTED (ARYL/HETEROARYL) METHYLENE)BENZENAMINE DERIVATIVES
... Schiff bases, such as nitrofurantoin or nifuroxazide, are commonly applied in medicine as antibacterial agents. They are well known for their biological application as antibacterial, antifungal, antiviral, anti- ...
15
PubMedCentral-PMC5735186.pdf
... A major finding in our study is that MPA treatment, but not LNG or NET, was able to decrease intracellu- lar TFV-DP concentrations, offering a potential explanation for the loss of anti-HIV activity. The ...
12
Project Nasah An investigation into the HIV treatment information and other needs of African people with HIV resident in England
... Adherence to chronic therapy is always challenging and complex, but anti-HIV therapy is unusual in that very high levels of adherence are necessary for success. These findings suggest that simply ...
48
“(Cyclohexyl Methylene) Bis-Diacyl Phloroglucinol: An Inhibitor of HIV-1 Integrase In Vitro” by Sudeep Sabde, Debashis Mitra, Sanjay Toshniwal, India.
... exhibits anti-HIV activity in TZMbl tissue culture only if preincubated with virus and added after infection of target ...on HIV IN and may ultimately lead to new classes of potent HIV ...
6
A new antisense tRNA construct for the genetic treatment of human immunodeficiency virus type 1 infection.
... the anti- HIV-1 potency of this therapeutic approach, it is remarkable that resistance to de novo HIV-1 infection can be conferred even to an uncloned cell population ...to HIV-1 by a ...
8
Characterization of the Outer Domain of the gp120 Glycoprotein from Human Immunodeficiency Virus Type 1
... the HIV-1 en- velope glycoproteins in the HIV-Ig and anti-HIV-1#1 and anti-HIV-1#2 sera, we measured the antibody titers specific for the outer domain in comparison with the ...
12
SYNTHESIS, ANTI VIRAL AND CYTOTOXICITY STUDIES OF SOME NOVEL N SUBSTITUTED BENZIMIDAZOLE DERIVATIVES
... screened anti-viral activity against a HIV -1 and -2 in MT-4 ...The anti-HIV activities of the new compounds were also screened for in vitro anti-viral activity against replication of ...
5
The HIV 1 integrase LEDGF allosteric inhibitor MUT A: resistance profile, impairment of virus maturation and infectivity but without influence on RNA packaging or virus immunoreactivity
... Background: HIV-1 Integrase (IN) interacts with the cellular co-factor LEDGF/p75 and tethers the HIV preintegration complex to the host genome enabling ...SIV. HIV-1 virions produced in the presence ...
17
Pathogenicity and immunogenicity of attenuated, nef deleted HIV 1 strains in vivo
... attenuated HIV vaccines are unlikely to be developed due to a myriad of safety concerns, opportunities exist to better understand the correlates of immune protection against HIV infection by studying rare ...
13
Regulation of Human Immunodeficiency Virus Replication by 2′,5′-Oligoadenylate-Dependent RNase L
... The anti-HIV effects of the 2-5A system are probably due to the stimulation of 2-5A synthetase activity by highly structured regions of HIV ...of HIV RNA is sufficiently double stranded to ...
7